Hemochromatosis

Introduction

Introduction to Hemochromatosis and Iron Metabolism

Hemochromatosis is a hereditary disorder characterized by excessive iron absorption and deposition in various organs, leading to tissue damage and dysfunction. Iron metabolism is tightly regulated to maintain homeostasis, as both iron deficiency and overload can have severe clinical consequences. This topic explores the biochemical pathways of iron absorption, transport, storage, and regulation, with a focus on the molecular mechanisms underlying hemochromatosis.

Clinical and Biochemical Significance

Iron is essential for numerous biological processes, including oxygen transport, DNA synthesis, and cellular respiration. However, excess iron catalyzes the formation of reactive oxygen species (ROS) via the Fenton reaction, leading to oxidative stress and cellular injury. Hemochromatosis primarily results from mutations in genes involved in iron regulation, such as HFE, leading to unchecked iron absorption and systemic iron overload.

Study

Iron Absorption and Dietary Regulation

Iron absorption occurs primarily in the duodenum and proximal jejunum. Dietary iron exists in two forms: heme iron (from animal sources) and non-heme iron (from plant sources). Heme iron is absorbed more efficiently via the heme carrier protein 1 (HCP1), while non-heme iron is reduced to ferrous iron (Fe²⁺) by duodenal cytochrome b (Dcytb) and transported into enterocytes via divalent metal transporter 1 (DMT1). Absorption is regulated by hepcidin, a peptide hormone that inhibits iron export from enterocytes and macrophages by binding to ferroportin, the sole iron exporter.

Iron Transport and Storage

Once absorbed, ferrous iron is oxidized to ferric iron (Fe³⁺) by hephaestin or ceruloplasmin and binds to transferrin for transport in the bloodstream. Transferrin delivers iron to cells via transferrin receptor 1 (TfR1), where it is endocytosed and released in acidic endosomes. Excess iron is stored in ferritin, a multimeric protein complex that sequesters iron in a non-toxic form. Ferritin levels are a key clinical marker of iron stores, with elevated levels indicating iron overload.

Hepcidin and Systemic Iron Regulation

Hepcidin is the central regulator of systemic iron homeostasis, synthesized primarily in the liver. It binds to ferroportin, inducing its internalization and degradation, thereby reducing iron export into the plasma. Hepcidin expression is regulated by iron levels, inflammation, and erythropoietic demand. In hemochromatosis, mutations in HFE, HJV, or HAMP genes disrupt hepcidin production or function, leading to inappropriately low hepcidin levels and unchecked iron absorption.

Genetic Basis of Hemochromatosis

Hereditary hemochromatosis is most commonly caused by mutations in the HFE gene, particularly the C282Y and H63D variants. These mutations impair the interaction between HFE and transferrin receptor 2 (TfR2), disrupting hepcidin signaling. Other forms of hemochromatosis result from mutations in HJV (hemojuvelin), HAMP (hepcidin), or TFR2, leading to more severe iron overload. Genetic testing is essential for diagnosis, particularly in patients with elevated serum ferritin or transferrin saturation.

Pathophysiology of Iron Overload

Chronic iron overload leads to progressive deposition in parenchymal organs, including the liver, heart, pancreas, and endocrine glands. Iron-mediated oxidative stress damages cellular membranes, proteins, and DNA, resulting in fibrosis, cirrhosis, cardiomyopathy, diabetes, and hypogonadism. The liver is the primary site of iron accumulation, and hepatic iron overload is a hallmark of hemochromatosis. Early diagnosis and therapeutic phlebotomy can prevent irreversible organ damage.

Summary

Key Takeaways

Hemochromatosis is a genetic disorder of iron overload caused by mutations in genes regulating hepcidin production or function. Iron metabolism is tightly controlled by hepcidin, which inhibits iron export via ferroportin. Excess iron generates reactive oxygen species, leading to oxidative damage and organ dysfunction. Early diagnosis through genetic testing and serum iron markers is critical for preventing complications.

Clinical Correlate

Patients with hemochromatosis often present with fatigue, arthralgia, and hepatomegaly, but may remain asymptomatic until advanced disease. Laboratory findings include elevated serum ferritin and transferrin saturation. Therapeutic phlebotomy is the mainstay of treatment, aiming to reduce iron stores and prevent organ damage. Screening of first-degree relatives is recommended due to the autosomal recessive inheritance pattern.

Biochemical Insights

The Fenton reaction highlights the dual role of iron as both an essential nutrient and a potential toxin. Understanding the molecular mechanisms of iron absorption, transport, and storage is crucial for diagnosing and managing iron-related disorders. Hepcidin agonists and ferroportin inhibitors are emerging as potential therapeutic targets for hemochromatosis and other iron overload conditions.